Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive

Monica B Kirby1, Brian M Petersen1, Jonathan G Faris1

  • 1Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80305.

Summary

Human antibody development pathways for SARS-CoV-2 Spike antibodies involve few mutations that significantly alter binding affinity. These mutations can occur in any order, with precursors needing only a slight affinity advantage to dominate the immune response.